Market Tracker

10/23 5:07am ET

Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC)

3.31
Data as of Oct 22
 +0.07 / +2.16%
Today’s Change
2.68
Today|||52-Week Range
5.25
-17.66%
Year-to-Date

Today’s Trading

Previous close3.24
Today’s open3.24
Day’s range-- - --
Volume141,485
Average volume (3 months)87,595
Market cap$73.5M
Dividend yield--
Data as of 10/22/2014

Growth & Valuation

Earnings growth (last year)+23.81%
Earnings growth (this year)+21.09%
Earnings growth (next 5 years)--
Revenue growth (last year)+1,471.01%
P/E ratioNM
Price/Sales56.21
Price/Book2.24

Competitors

 Today’s
change
Today’s
% change
ARQLArQule Inc+0.02+1.74%
IMMYImprimis Pharmaceuti...+0.10+1.27%
GLMDGalmed Pharmaceutica...+0.05+0.77%
HSKAHeska Corp-0.16-1.32%
Data as of 10/22/2014

Financials

Next reporting dateNovember 17, 2014
EPS forecast (this quarter)-$0.27
Annual revenue (last year)$1.1M
Annual profit (last year)-$10.2M
Net profit margin-941.88%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Spiro Rombotis
COO, CFO, Secretary, Director &
Executive VP
Paul McBarron
Corporate headquarters
Berkeley Heights, New Jersey

Forecasts